Financial Performance - The company's operating revenue for Q3 2024 was ¥278,688,653.46, representing a decrease of 5.56% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was -¥2,378,018.96, a decline of 165.13% year-over-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was -¥1,935,148.14, reflecting a decrease of 154.01% compared to the same period last year[3]. - The total operating profit decreased by 231.88 million, primarily due to a decline in sales and gross margin[8]. - The total profit decreased by 263.81 million, attributed to a drop in sales and gross margin[8]. - The company incurred a total operating loss of -30,975,810.08 CNY in Q3 2024, compared to an operating profit of 23,487,958.03 CNY in Q3 2023[14]. - The net profit for Q3 2024 was -26,964,206.82 CNY, compared to a net profit of 20,074,507.75 CNY in Q3 2023, representing a significant decline[14]. - The total comprehensive income for Q3 2024 was -41,964,149.95 CNY, down from 19,570,448.38 CNY in the same period last year[15]. Cash Flow - The company reported a net cash flow from operating activities of -¥12,612,234.02, indicating a significant decline[3]. - Cash flow from operating activities for the year-to-date period was 85.12 million, mainly due to a reduction in bank bill guarantee deposits and expenses[8]. - Cash flow from investing activities for the year-to-date period was -357.15 million, resulting from the purchase of financial products exceeding the amount redeemed[8]. - Cash flow from financing activities for the year-to-date period was 162.40 million, primarily due to an increase in cash received from borrowings[8]. - Cash flow from operating activities for the first nine months of 2024 was 697,162,025.77 CNY, a decrease from 901,436,438.45 CNY in the previous year[16]. - The net cash flow from operating activities in Q3 2024 was -12,612,234.02 CNY, compared to -84,765,202.83 CNY in Q3 2023, indicating an improvement[17]. - The company’s investment activities resulted in a net cash outflow of -252,940,834.35 CNY in Q3 2024, compared to -55,329,798.04 CNY in Q3 2023[17]. Assets and Liabilities - The total assets at the end of Q3 2024 amounted to ¥2,643,895,999.24, a decrease of 1.77% from the end of the previous year[3]. - Total liabilities decreased to CNY 1,092,348,437.34 from CNY 1,132,692,757.72 in the previous quarter, reflecting a reduction of approximately 3.6%[12]. - The company's total equity attributable to shareholders was CNY 1,553,256,396.85, slightly down from CNY 1,558,235,015.21 in the previous quarter[12]. - The company’s cash and cash equivalents decreased from 847.75 million to 606.36 million[10]. - The company’s inventory decreased from 378.45 million to an unspecified amount in the current report[10]. - Cash and cash equivalents decreased from CNY 1,674,888,792.49 to CNY 1,582,824,316.13, indicating a decline of about 5.5%[12]. - Short-term borrowings increased significantly to CNY 164,874,760.30 from CNY 50,039,178.08, marking an increase of approximately 229.5%[12]. Shareholder Information - The company had 17,595 total common shareholders at the end of the reporting period[9]. - The largest shareholder, Yin Fengshan, holds 40.98% of the shares, totaling 67,725,478 shares[9]. Revenue and Costs - The company experienced a 20.47% decrease in revenue for the year-to-date period compared to the same period last year[2]. - Total operating revenue for the first three quarters of 2024 was CNY 799,799,696.65, a decrease from CNY 1,005,597,225.86 in the same period of 2023, representing a decline of approximately 20.5%[13]. - Total operating costs for the first three quarters of 2024 were CNY 831,464,675.18, down from CNY 988,797,118.43 in 2023, indicating a reduction of about 15.9%[13]. - Research and development expenses for the first three quarters of 2024 were CNY 32,201,882.74, slightly lower than CNY 32,341,126.03 in the same period of 2023[13]. Future Plans - The company plans to continue investing in new projects, particularly in fine chemical projects in Hubei[6].
丰山集团(603810) - 2024 Q3 - 季度财报